title: Macrolide antibiotics for prevention of chronic obstructive pulmonary disease exacerbations: are we there yet?
authors.affiliation: 1 Division of Pulmonary Diseases and Critical Care Medicine University of Texas Health Science Center at San Antonio San Antonio, Texas and.
authors.forename: Marcos I
authors.initials: MI
authors.lastname: Restrepo
authors.forename: Antonio
authors.initials: A
authors.lastname: Anzueto
mesh_terms: D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D017963:Azithromycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002319:Cardiovascular System / Q000187:drug effects*; D015897:Comorbidity; D018450:Disease Progression; D024901:Drug Resistance, Multiple, Bacterial / Q000187:drug effects*; D034381:Hearing Loss / Q000139:chemically induced*; D006801:Humans; D018942:Macrolides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D018727:Muscarinic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D018570:Risk Assessment
chemical_list: D000900:Anti-Bacterial Agents; D001993:Bronchodilator Agents; D018942:Macrolides; D018727:Muscarinic Antagonists; D017963:Azithromycin